TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 08 04 2020
accepted: 24 06 2020
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 14 4 2021
Statut: epublish

Résumé

Adoptive T cell therapy (ACT) is a rapidly evolving therapeutic approach designed to harness T cell specificity and function to fight diseases. Based on the evidence that T lymphocytes can mediate a potent anti-tumor response, initially ACT solely relied on the isolation,

Identifiants

pubmed: 33013822
doi: 10.3389/fimmu.2020.01689
pmc: PMC7494743
doi:

Substances chimiques

Receptors, Chimeric Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1689

Informations de copyright

Copyright © 2020 Manfredi, Cianciotti, Potenza, Tassi, Noviello, Biondi, Ciceri, Bonini and Ruggiero.

Références

Elife. 2016 Nov 08;5:
pubmed: 27823582
Nat Immunol. 2017 Aug;18(8):940-950
pubmed: 28628092
Trends Immunol. 2016 Mar;37(3):193-207
pubmed: 26839260
Nat Immunol. 2018 Jun;19(6):538-546
pubmed: 29777219
Front Immunol. 2014 Feb 24;5:69
pubmed: 24605112
Immunol Today. 1990 Mar;11(3):83-8
pubmed: 2186745
Front Immunol. 2016 Dec 12;7:573
pubmed: 28018343
Nature. 1986 Mar 20-26;320(6059):232-8
pubmed: 2421164
J Clin Invest. 2005 Jun;115(6):1616-26
pubmed: 15931392
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Immunol Rev. 2002 Oct;188:51-64
pubmed: 12445281
Eur J Immunol. 1994 Dec;24(12):3038-43
pubmed: 7805731
Nat Med. 2016 Apr;22(4):433-8
pubmed: 26901407
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2965-70
pubmed: 25392179
J Immunol Methods. 1990 Apr 17;128(2):189-201
pubmed: 1691237
Curr Gene Ther. 2011 Feb;11(1):11-27
pubmed: 21182466
Nat Methods. 2013 Apr;10(4):361-5
pubmed: 23503052
Nat Biotechnol. 2005 Mar;23(3):349-54
pubmed: 15723046
Nat Methods. 2014 Apr;11(4):429-35
pubmed: 24531420
Genetics. 2011 Aug;188(4):773-82
pubmed: 21828278
Clin Cancer Res. 2006 Sep 15;12(18):5423-34
pubmed: 17000676
J Immunother. 2016 Jun;39(5):191-201
pubmed: 27163739
Oncotarget. 2017 Dec 27;9(4):5208-5215
pubmed: 29435173
Science. 2001 Jul 13;293(5528):248-50
pubmed: 11452114
Nat Med. 2013 Nov;19(11):1534-41
pubmed: 24121928
Nucleic Acids Res. 2015 Mar 31;43(6):3389-404
pubmed: 25712100
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17561-6
pubmed: 23045683
Cell Res. 2013 Nov;23(11):1322-5
pubmed: 24145754
Science. 2002 Oct 25;298(5594):850-4
pubmed: 12242449
Curr Opin Immunol. 2013 Apr;25(2):214-21
pubmed: 23298609
Leukemia. 2006 Oct;20(10):1738-50
pubmed: 16932347
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10972-7
pubmed: 20534461
Science. 1997 Jun 13;276(5319):1719-24
pubmed: 9180086
Cancer Cell. 2018 Apr 9;33(4):547-562
pubmed: 29634943
N Engl J Med. 2011 Aug 25;365(8):725-33
pubmed: 21830940
N Engl J Med. 1988 Dec 22;319(25):1676-80
pubmed: 3264384
Science. 1998 Feb 13;279(5353):1054-7
pubmed: 9461441
J Immunother Cancer. 2016 Apr 19;4:21
pubmed: 27096098
Nature. 2015 Apr 9;520(7546):186-91
pubmed: 25830891
Mol Ther. 2004 Feb;9(2):147-56
pubmed: 14759798
Cell Death Dis. 2015 Jun 18;6:e1792
pubmed: 26086965
Oncoimmunology. 2018 Apr 18;7(8):e1450715
pubmed: 30221044
Stem Cells. 2011 Oct;29(10):1479-84
pubmed: 21898683
Front Immunol. 2019 Oct 22;10:2501
pubmed: 31695703
Sci Transl Med. 2013 Aug 7;5(197):197ra103
pubmed: 23926201
N Engl J Med. 2002 Apr 18;346(16):1185-93
pubmed: 11961146
Nat Med. 2018 Jul;24(7):986-993
pubmed: 29942092
Clin Cancer Res. 2018 Jun 15;24(12):2920-2934
pubmed: 29391351
Nat Med. 2019 Aug;25(8):1251-1259
pubmed: 31359002
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 26853428
Cancer Immun. 2008 Apr 22;8:7
pubmed: 18426187
Blood. 2017 Aug 3;130(5):606-618
pubmed: 28637663
Oncoimmunology. 2016 Jun 27;5(7):e1196312
pubmed: 27622051
J Clin Oncol. 2011 Mar 1;29(7):917-24
pubmed: 21282551
Blood. 2019 Feb 7;133(6):550-565
pubmed: 30530751
JCI Insight. 2019 Oct 3;4(19):
pubmed: 31465302
Expert Opin Biol Ther. 2015;15(9):1337-48
pubmed: 26125492
Blood Adv. 2019 Jul 9;3(13):2022-2034
pubmed: 31289029
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Blood. 2009 Nov 5;114(19):4099-107
pubmed: 19706884
J Clin Invest. 2016 Sep 1;126(9):3363-76
pubmed: 27482888
Cell Mol Immunol. 2010 Sep;7(5):389-95
pubmed: 20514052
Cancer Res. 2000 Aug 15;60(16):4499-506
pubmed: 10969798
Clin Cancer Res. 2015 Mar 1;21(5):1019-27
pubmed: 25538264
Nat Biotechnol. 2017 Dec;35(12):1188-1195
pubmed: 29106410
Science. 2016 Jun 10;352(6291):1337-41
pubmed: 27198675
N Engl J Med. 2014 Oct 16;371(16):1507-17
pubmed: 25317870
Nat Biotechnol. 2011 Feb;29(2):143-8
pubmed: 21179091
Mol Ther. 2011 Mar;19(3):620-6
pubmed: 21157437
Cell Rep. 2017 Jul 18;20(3):750-756
pubmed: 28723575
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
J Immunother. 2005 Jan-Feb;28(1):53-62
pubmed: 15614045
Cancer Res. 2011 Oct 15;71(20):6391-9
pubmed: 21900403
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
J Clin Invest. 2015 Oct 1;125(10):3981-91
pubmed: 26389673
Nucleic Acids Res. 2014 Feb;42(4):2591-601
pubmed: 24285304
Trends Immunol. 2005 Feb;26(2):111-7
pubmed: 15668127
Cancer Immunol Immunother. 2004 Mar;53(3):187-95
pubmed: 14758508
Gene Ther. 2009 Aug;16(8):1042-9
pubmed: 19494842
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Expert Opin Biol Ther. 2015;15(8):1145-54
pubmed: 25985798
Blood. 2009 Jan 29;113(5):1006-15
pubmed: 18978209
Cancer Res. 2009 Apr 1;69(7):3077-85
pubmed: 19293190
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Nat Commun. 2017 Nov 23;8(1):1738
pubmed: 29170503
Nat Med. 2018 Aug;24(8):1216-1224
pubmed: 30082871
Nat Biotechnol. 2019 Sep;37(9):1041-1048
pubmed: 31477922
Nat Commun. 2015 Sep 01;6:8081
pubmed: 26324409
Cancer Discov. 2014 May;4(5):522-6
pubmed: 24795012
Chin J Cancer Res. 2014 Feb;26(1):104-11
pubmed: 24653632
Gene Ther. 2020 Mar 5;:
pubmed: 32139891
Clin Cancer Res. 2010 Jan 1;16(1):164-73
pubmed: 20028741
Cancer Res. 2007 Apr 15;67(8):3898-903
pubmed: 17440104
Nat Commun. 2015 May 13;6:7114
pubmed: 25968334
PLoS One. 2007 Aug 29;2(8):e796
pubmed: 17726526
Cancer Chemother Pharmacol. 2019 May;83(5):911-920
pubmed: 30848330
J Immunol. 1991 Jul 15;147(2):729-37
pubmed: 1830072
Nat Rev Genet. 2006 Sep;7(9):703-13
pubmed: 16909129
Clin Cancer Res. 2010 Dec 15;16(24):6122-31
pubmed: 20668005
Blood. 2009 Aug 20;114(8):1537-44
pubmed: 19423728
Nat Med. 2015 Aug;21(8):914-921
pubmed: 26193344
Proc Natl Acad Sci U S A. 1986 May;83(10):3194-8
pubmed: 3458176
Nat Biotechnol. 2014 Jun;32(6):569-76
pubmed: 24770325
Breast Cancer Res Treat. 2014 Jul;146(1):15-24
pubmed: 24842267
Blood. 2015 Apr 30;125(18):2865-74
pubmed: 25736310
Blood. 1991 Oct 15;78(8):2120-30
pubmed: 1912589
Hepatology. 2019 May;69(5):2061-2075
pubmed: 30561769
PLoS One. 2012;7(6):e38783
pubmed: 22761704
Mol Ther. 2009 Apr;17(4):742-9
pubmed: 19209146
Front Immunol. 2019 Dec 11;10:2857
pubmed: 31921127
Mol Ther. 2016 Apr;24(4):678-84
pubmed: 26867951
Front Immunol. 2018 May 03;9:978
pubmed: 29774034
J Exp Med. 1998 Dec 21;188(12):2205-13
pubmed: 9858507
Anticancer Res. 2009 Nov;29(11):4751-8
pubmed: 20032431
Immunity. 1998 Aug;9(2):179-86
pubmed: 9729038
Prostate. 2004 Jun 1;59(4):440-7
pubmed: 15065093
Melanoma Res. 2020 Feb;30(1):14-25
pubmed: 31524789
Sci Transl Med. 2013 Mar 20;5(177):177ra38
pubmed: 23515080
Immunity. 1998 Apr;8(4):413-25
pubmed: 9586632
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
Eur J Cancer. 2016 Feb;54:139-148
pubmed: 26765102
Cancer Res. 2005 Mar 1;65(5):1761-9
pubmed: 15753372
Immunol Ser. 1994;61:175-8
pubmed: 8011741
Mol Genet Metab. 2003 Sep-Oct;80(1-2):148-58
pubmed: 14567964
J Clin Invest. 2015 May;125(5):2046-58
pubmed: 25866972
Nat Commun. 2017 May 24;8:15221
pubmed: 28537262
Immunity. 2005 Oct;23(4):344-6
pubmed: 16226499
Immunity. 2001 Jan;14(1):21-32
pubmed: 11163227
N Engl J Med. 2019 Mar 7;380(10):947-959
pubmed: 30855744
Nat Commun. 2017 Jul 17;8:16073
pubmed: 28714465
Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123068
Nat Rev Immunol. 2015 Nov;15(11):669-82
pubmed: 26471778
Nature. 2019 Dec;576(7787):471-476
pubmed: 31827283
Blood. 2018 Jan 4;131(1):108-120
pubmed: 29051183
Cancer Res. 2010 Aug 1;70(15):6171-80
pubmed: 20631075
Science. 2013 Aug 23;341(6148):1233151
pubmed: 23845947
J Surg Oncol. 2004 Jul 15;87(1):46-52
pubmed: 15221919
Clin Cancer Res. 2014 May 1;20(9):2457-65
pubmed: 24634374
Front Immunol. 2018 Sep 11;9:2076
pubmed: 30258445
Cancer Discov. 2018 Aug;8(8):944-957
pubmed: 29891538
J Clin Oncol. 1999 Aug;17(8):2521-9
pubmed: 10561318
Cancer Immun. 2003 Dec 18;3:19
pubmed: 14680360
Nature. 2017 Mar 2;543(7643):113-117
pubmed: 28225754
Nat Commun. 2019 Mar 22;10(1):1336
pubmed: 30902997
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
J Exp Med. 2011 Sep 26;208(10):1949-62
pubmed: 21930770
Nat Commun. 2019 Mar 25;10(1):1065
pubmed: 30911002
Oncotarget. 2016 Apr 12;7(15):20999-1012
pubmed: 27007162
Genome Res. 2014 Jun;24(6):1012-9
pubmed: 24696461
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6973-8
pubmed: 23576742
Nat Biotechnol. 2018 Sep;36(8):765-771
pubmed: 30010673
Cancer Chemother Pharmacol. 2004 Jul;54(1):95-100
pubmed: 15118836
Cancer Cell. 2013 Mar 18;23(3):277-86
pubmed: 23518347
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7
pubmed: 12826605
Cancer Res. 2016 May 1;76(9):2525-39
pubmed: 26980767
Science. 1986 Sep 19;233(4770):1318-21
pubmed: 3489291
Front Med. 2017 Dec;11(4):554-562
pubmed: 28625015
J Clin Oncol. 2005 Feb 1;23(4):741-50
pubmed: 15613700
Cancer Res. 2017 Aug 15;77(16):4434-4447
pubmed: 28655790
Cancer Res. 2015 Sep 15;75(18):3853-64
pubmed: 26183927
J Clin Invest. 2011 Jun;121(6):2350-60
pubmed: 21555851
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Br J Cancer. 2013 Oct 29;109(9):2412-23
pubmed: 24129241
Gene Ther. 2001 Aug;8(16):1248-54
pubmed: 11509958
Nat Rev Cancer. 2006 Jul;6(7):506-20
pubmed: 16794634
J Immunol. 2018 Feb 1;200(3):1088-1100
pubmed: 29288199
J Immunol. 1992 Sep 1;149(5):1788-94
pubmed: 1380540
Nat Med. 2019 Jul;25(7):1064-1072
pubmed: 31235963
J Clin Invest. 2016 Jun 1;126(6):2123-38
pubmed: 27111235
Cell. 1997 Nov 14;91(4):501-10
pubmed: 9390559
J Clin Invest. 2014 May;124(5):2246-59
pubmed: 24667641
Scand J Immunol. 2000 Feb;51(2):128-33
pubmed: 10652158
J Autoimmun. 2017 Dec;85:141-152
pubmed: 28843422
Mol Ther. 2006 Mar;13(3):625-30
pubmed: 16368272
Nat Med. 2019 Sep;25(9):1408-1414
pubmed: 31477906
Blood. 2013 Jan 24;121(4):573-84
pubmed: 23160470
Cancer Res. 2017 Feb 15;77(4):851-861
pubmed: 27979840
J Immunol Methods. 2002 Sep 1;267(1):71-7
pubmed: 12135801
Cancer Immunol Res. 2018 Sep;6(9):990-1000
pubmed: 30181337
Science. 1991 Mar 15;251(4999):1363-6
pubmed: 1848369
Front Immunol. 2018 Nov 29;9:2810
pubmed: 30555481
J Clin Invest. 2014 Dec;124(12):5352-67
pubmed: 25347474
J Virol. 1998 Oct;72(10):8150-7
pubmed: 9733856
Blood. 2009 Jul 16;114(3):535-46
pubmed: 19451549
Nat Med. 2010 Sep;16(9):1029-34
pubmed: 20693993
Gynecol Oncol. 2012 Feb;124(2):303-10
pubmed: 22040835
Nature. 1984 Mar 8-14;308(5955):145-9
pubmed: 6336315
J Clin Invest. 2003 Mar;111(5):639-47
pubmed: 12618518
Nat Med. 2019 Jan;25(1):89-94
pubmed: 30510250
J Immunother. 2008 Oct;31(8):742-51
pubmed: 18779745
FASEB J. 2015 Jan;29(1):227-38
pubmed: 25361735
J Clin Oncol. 2018 Apr 10;36(11):1128-1139
pubmed: 29315015
Mol Ther. 2008 Mar;16(3):590-8
pubmed: 18180772
Blood. 2007 Jun 1;109(11):4708-15
pubmed: 17327417
Blood. 2006 Mar 1;107(5):1828-36
pubmed: 16293601
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-60
pubmed: 8577732
Cancer Res. 2009 Dec 1;69(23):9003-11
pubmed: 19903853
Nat Rev Cancer. 2011 Dec 01;12(1):51-8
pubmed: 22129804
Science. 2013 Aug 23;341(6148):1233158
pubmed: 23845948
Cell Rep. 2020 Jan 21;30(3):714-724.e5
pubmed: 31968248
Tissue Antigens. 2002 Nov;60(5):365-71
pubmed: 12492812
Clin Cancer Res. 2003 Feb;9(2):606-12
pubmed: 12576425
Semin Cancer Biol. 2020 Oct;65:176-188
pubmed: 31874281
J Immunol. 1995 Jan 15;154(2):762-71
pubmed: 7814882
Cancer Res. 2006 Sep 1;66(17):8878-86
pubmed: 16951205
Nature. 2019 May;569(7756):433-437
pubmed: 30995674
Mol Ther. 2016 Mar;24(3):570-81
pubmed: 26502778
Blood. 2007 Mar 15;109(6):2331-8
pubmed: 17082316
Blood. 2001 Mar 1;97(5):1249-57
pubmed: 11222367
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3789-94
pubmed: 9108056
Nucleic Acids Res. 2006;34(17):4791-800
pubmed: 16971456
Nature. 2018 Jun;558(7709):307-312
pubmed: 29849141
Blood. 2002 May 1;99(9):3179-87
pubmed: 11964281
Int J Cancer. 2016 Mar 1;138(5):1207-19
pubmed: 26414794
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4558-4566
pubmed: 30700545
Clin Cancer Res. 2019 Aug 1;25(15):4820-4831
pubmed: 31076549
Mol Ther. 2017 Apr 5;25(4):949-961
pubmed: 28237835
Nat Methods. 2017 Jun;14(6):607-614
pubmed: 28459458
Cell Stem Cell. 2016 Jul 7;19(1):107-19
pubmed: 27237736
Blood. 2007 Jan 1;109(1):235-43
pubmed: 16968899
Nature. 1984 Mar 8-14;308(5955):153-8
pubmed: 6546606
J Immunother. 2008 Jun;31(5):500-5
pubmed: 18463534
Curr Opin Immunol. 2013 Apr;25(2):277-83
pubmed: 23619309
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
J Biochem. 2008 Jun;143(6):725-9
pubmed: 18218651
J Clin Invest. 2016 Aug 1;126(8):3130-44
pubmed: 27454297
Trends Pharmacol Sci. 2016 Mar;37(3):220-230
pubmed: 26705086
Nat Commun. 2020 Jan 10;11(1):219
pubmed: 31924795
Nat Med. 2013 Jun;19(6):747-52
pubmed: 23644516
J Cell Mol Med. 2020 Apr;24(7):3766-3778
pubmed: 32096600
Gene Ther. 2014 Jun;21(6):539-48
pubmed: 24670996
Clin Cancer Res. 2015 May 15;21(10):2268-77
pubmed: 25855804
J Clin Invest. 2008 Jan;118(1):294-305
pubmed: 18060041
EMBO J. 1992 Dec;11(13):5071-8
pubmed: 1334463
Nature. 2014 Jun 12;510(7504):235-240
pubmed: 24870228
Front Immunol. 2019 May 09;10:1023
pubmed: 31156623
Cytogenet Genome Res. 2005;110(1-4):426-40
pubmed: 16093695
Oncoimmunology. 2017 Dec 26;7(3):e1407898
pubmed: 29399409
Nat Immunol. 2001 Oct;2(10):957-61
pubmed: 11577349
Eur J Immunol. 2013 Nov;43(11):3038-50
pubmed: 23893393
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Immunogenetics. 1999 Nov;50(3-4):213-9
pubmed: 10602881
Nature. 2019 Jan;565(7739):366-371
pubmed: 30598548
Hum Gene Ther. 2000 May 20;11(8):1151-64
pubmed: 10834617
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997304
J Mol Biol. 2001 Apr 13;307(5):1305-15
pubmed: 11292343
Mol Ther. 2008 Apr;16(4):665-72
pubmed: 18362924
Clin Cancer Res. 2013 Oct 15;19(20):5636-46
pubmed: 23873688
Nat Med. 2017 May 5;23(5):540-547
pubmed: 28475571
Cancer Res. 2005 Mar 15;65(6):2457-64
pubmed: 15781662
Cell. 2013 Sep 12;154(6):1370-9
pubmed: 23992847
Virology. 2007 Nov 25;368(2):309-16
pubmed: 17675129
Sci Transl Med. 2013 Feb 27;5(174):174ra27
pubmed: 23447018
Immunol Cell Biol. 2011 Mar;89(3):396-407
pubmed: 21301477
Clin Immunol. 2001 Feb;98(2):220-8
pubmed: 11161978
Nat Med. 2018 May;24(5):563-571
pubmed: 29713085
Biomaterials. 2018 Mar;159:161-173
pubmed: 29329051
Br J Cancer. 2009 May 5;100(9):1444-51
pubmed: 19352387
Expert Rev Clin Immunol. 2013 Dec;9(12):1151-3
pubmed: 24215403
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Oncoimmunology. 2018 Mar 19;7(7):e1442163
pubmed: 29900048
Nat Biotechnol. 2011 Aug 07;29(9):816-23
pubmed: 21822255
Oncotarget. 2016 Feb 2;7(5):5110-7
pubmed: 26819371
Hum Gene Ther. 2014 Apr;25(4):265-84
pubmed: 24512150
J Immunol. 2013 Sep 1;191(5):2217-25
pubmed: 23904171
Clin Cancer Res. 2015 Oct 1;21(19):4431-9
pubmed: 26429982
Nat Med. 2010 May;16(5):565-70, 1p following 570
pubmed: 20400962
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Oncoimmunology. 2019 Nov 24;9(1):1682381
pubmed: 32002290
Br J Haematol. 1988 Jun;69(2):239-45
pubmed: 3291930
Hum Gene Ther. 2005 Apr;16(4):457-72
pubmed: 15871677
J Clin Oncol. 2016 Jul 10;34(20):2389-97
pubmed: 27217459
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
Lab Invest. 2017 Jun;97(6):669-697
pubmed: 28346400
Nat Biotechnol. 2015 Feb;33(2):179-86
pubmed: 25503383
J Transl Med. 2016 Jun 24;14(1):187
pubmed: 27342639
Sci Rep. 2017 Apr 7;7(1):737
pubmed: 28389661
Nature. 2019 Dec;576(7786):293-300
pubmed: 31802004
Cancer Immunol Res. 2015 Jun;3(6):620-30
pubmed: 25701326
J Clin Invest. 2019 Nov 1;129(11):4992-5004
pubmed: 31609250
Cancer Res. 2003 Sep 15;63(18):6076-83
pubmed: 14522938
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2211-5
pubmed: 2156265
Clin Cancer Res. 2020 Jan 15;26(2):505-517
pubmed: 31649042
Blood. 2006 Mar 15;107(6):2294-302
pubmed: 16282341
Nature. 2017 Dec 14;552(7684):253-257
pubmed: 29211713
Cancer. 2003 Sep 1;98(5):1089-99
pubmed: 12942579
Sci Rep. 2018 Apr 3;8(1):5549
pubmed: 29615718
Ann Oncol. 2019 Dec 1;30(12):1902-1913
pubmed: 31566658
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
Clin Cancer Res. 2019 Apr 1;25(7):2096-2108
pubmed: 30573690
Oncotarget. 2016 Jul 12;7(28):43010-43026
pubmed: 27177227
Curr Opin Immunol. 1996 Feb;8(1):75-81
pubmed: 8729449
Ann Surg Oncol. 2009 Sep;16(9):2645-53
pubmed: 19588204
N Engl J Med. 2011 Nov 3;365(18):1673-83
pubmed: 22047558
Nat Biotechnol. 2015 Feb;33(2):175-8
pubmed: 25599175
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8061-6
pubmed: 22566637
Clin Cancer Res. 2012 Feb 1;18(3):678-87
pubmed: 22190592
Mol Ther. 2010 Jun;18(6):1200-9
pubmed: 20372108
Blood. 2005 Jan 1;105(1):241-50
pubmed: 15345595
Clin Cancer Res. 2009 Jan 1;15(1):169-80
pubmed: 19118044
Blood. 2015 Apr 30;125(18):2855-64
pubmed: 25742699
Nat Biotechnol. 1997 Sep;15(9):871-5
pubmed: 9306402
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Blood. 1990 Dec 15;76(12):2462-5
pubmed: 2265242
Nat Biotechnol. 2015 Sep;33(9):985-989
pubmed: 26121415
Mol Ther. 2019 Apr 10;27(4):710-728
pubmed: 30846391
Mol Ther. 2008 Feb;16(2):352-8
pubmed: 18026168
Haematologica. 2012 Aug;97(8):1205-8
pubmed: 22511490
Clin Cancer Res. 2020 Jan 15;26(2):450-464
pubmed: 31857430
Nat Biotechnol. 2013 Sep;31(9):822-6
pubmed: 23792628
Gene Ther. 2002 Oct;9(20):1359-68
pubmed: 12365001
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):720-4
pubmed: 8421711
J Immunother. 2013 Feb;36(2):133-51
pubmed: 23377668
Science. 2006 Oct 6;314(5796):126-9
pubmed: 16946036
N Engl J Med. 2011 Dec 1;365(22):2055-66
pubmed: 22129252
Leukemia. 2018 Sep;32(9):1970-1983
pubmed: 29483708
Clin Cancer Res. 2017 May 1;23(9):2255-2266
pubmed: 27815355
Nat Biotechnol. 2015 Apr;33(4):402-7
pubmed: 25774714
J Exp Med. 2011 Mar 14;208(3):469-78
pubmed: 21339327
Cancer Immunol Immunother. 2019 Mar;68(3):365-377
pubmed: 30523370
Science. 1996 Jul 5;273(5271):104-6
pubmed: 8658175
Blood. 1998 Apr 15;91(8):2925-34
pubmed: 9531603
Blood Adv. 2020 Feb 11;4(3):560-572
pubmed: 32045475
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
J Immunother Cancer. 2019 Oct 24;7(1):276
pubmed: 31651363
Mol Ther. 2016 Jun;24(6):1078-1089
pubmed: 26945006
Blood. 2013 Aug 8;122(6):863-71
pubmed: 23770775
Clin Cancer Res. 2016 Apr 15;22(8):1856-64
pubmed: 27084739
J Clin Oncol. 2008 Nov 10;26(32):5233-9
pubmed: 18809613
Sci Transl Med. 2015 Aug 19;7(301):301ra131
pubmed: 26290413
Leukemia. 2007 May;21(5):943-8
pubmed: 17361226
Br J Cancer. 2005 Mar 14;92(5):913-20
pubmed: 15714205
Blood. 2010 Nov 18;116(20):4099-102
pubmed: 20668228
Sci Transl Med. 2015 Dec 9;7(317):317ra198
pubmed: 26659572
Blood. 2008 Jun 1;111(11):5326-33
pubmed: 18276844
Cancer Res. 1995 Feb 15;55(4):748-52
pubmed: 7531614
J Exp Med. 2011 Mar 14;208(3):479-90
pubmed: 21339324
J Clin Invest. 2018 May 1;128(5):2010-2024
pubmed: 29485974
Nat Med. 2012 May;18(5):807-815
pubmed: 22466705
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80
pubmed: 20385810
Cancer Res. 2010 Nov 15;70(22):9053-61
pubmed: 20926399
J Exp Med. 1999 Feb 1;189(3):461-70
pubmed: 9927508
Nat Immunol. 2001 Oct;2(10):962-70
pubmed: 11577350
Blood. 1990 Feb 1;75(3):555-62
pubmed: 2297567
J Bacteriol. 1987 Dec;169(12):5429-33
pubmed: 3316184
Nat Biotechnol. 2016 Oct;34(10):1037-1045
pubmed: 27571370
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Sci Rep. 2016 Jan 28;6:20070
pubmed: 26818188
Nat Rev Immunol. 2016 Oct;16(10):599-611
pubmed: 27526640
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723
N Engl J Med. 1985 Apr 25;312(17):1100-11
pubmed: 3885036
Blood. 1977 Apr;49(4):511-33
pubmed: 14751
Front Immunol. 2020 Jun 19;11:1217
pubmed: 32636841
J Immunol. 2008 May 1;180(9):6116-31
pubmed: 18424733
J Immunother Cancer. 2018 Oct 11;6(1):106
pubmed: 30314524
Blood. 2005 May 15;105(10):3939-44
pubmed: 15671442
J Clin Oncol. 1988 May;6(5):839-53
pubmed: 3259261
Oncoimmunology. 2012 Nov 1;1(8):1409-1410
pubmed: 23243610
Clin Cancer Res. 2015 Jun 15;21(12):2840-50
pubmed: 25712684
J Clin Oncol. 2015 May 10;33(14):1543-50
pubmed: 25823737
Science. 2020 Feb 28;367(6481):
pubmed: 32029687
Cancer Immunol Immunother. 2014 Nov;63(11):1163-76
pubmed: 25082071
Am J Hematol. 2018 Jun;93(6):786-793
pubmed: 29603337
J Immunol. 2008 Jun 1;180(11):7736-46
pubmed: 18490778
J Immunol. 2012 Mar 15;188(6):2687-94
pubmed: 22323546
Mol Ther. 2008 Mar;16(3):580-9
pubmed: 18227839
PLoS Biol. 2004 Aug;2(8):E234
pubmed: 15314653
Lancet Oncol. 2009 May;10(5):489-500
pubmed: 19345145
Lung. 2009 Nov-Dec;187(6):401-11
pubmed: 19795170
Int J Cancer. 1994 Jun 15;57(6):805-13
pubmed: 8206676
J Immunol. 1999 Jul 1;163(1):507-13
pubmed: 10384155
Science. 2003 May 2;300(5620):763
pubmed: 12730593
Nat Immunol. 2017 Nov;18(11):1207-1217
pubmed: 28892469
Sci Rep. 2018 Jan 17;8(1):888
pubmed: 29343825
Cancer Immunol Res. 2016 Apr;4(4):354-65
pubmed: 26880715
Nat Rev Immunol. 2002 Jul;2(7):512-9
pubmed: 12094225
PLoS One. 2013 Jun 28;8(6):e68201
pubmed: 23840834
Blood. 2017 Nov 2;130(18):1985-1994
pubmed: 28860210
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Cell. 2015 Sep 10;162(6):1257-70
pubmed: 26343581
Mol Biotechnol. 2007 May;36(1):71-80
pubmed: 17827541
Nat Commun. 2016 Aug 30;7:12624
pubmed: 27571927
Clin Cancer Res. 2019 Apr 15;25(8):2610-2620
pubmed: 30647079
N Engl J Med. 1957 Sep 12;257(11):491-6
pubmed: 13464965
Front Pharmacol. 2018 Oct 01;9:1118
pubmed: 30327605
Science. 1996 Mar 22;271(5256):1734-6
pubmed: 8596936
Nucleic Acids Res. 2011 Nov;39(21):9283-93
pubmed: 21813459
N Engl J Med. 2008 Jun 19;358(25):2698-703
pubmed: 18565862
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6820-4
pubmed: 2821545

Auteurs

Francesco Manfredi (F)

Vita-Salute San Raffaele University, Milan, Italy.
Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Beatrice Claudia Cianciotti (BC)

Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Fondazione Centro San Raffaele, Milan, Italy.

Alessia Potenza (A)

Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
School of Medicine and Surgery, University of Milano - Bicocca, Milan, Italy.

Elena Tassi (E)

Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maddalena Noviello (M)

Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Andrea Biondi (A)

Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Monza, Italy.

Fabio Ciceri (F)

Vita-Salute San Raffaele University, Milan, Italy.
Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Chiara Bonini (C)

Vita-Salute San Raffaele University, Milan, Italy.
Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Eliana Ruggiero (E)

Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH